In the present study, we verified the enhanced NCX1 expression in human primary GC tissues and cells; and the enhanced NCX1 expression was correlated with larger tumor size, higher histological grade, lymphatic metastasis, advanced clinical stage and poor prognosis, which strongly suggests NCX1 as a potential marker for GC prognosis. This evidence concerns the gene SLC8A1 and gastric cancer.